Ambea account plan
Healthcare services and staffing
At a glance
Ambea is a Nordic care company with around 1,050 units and 41,000+ employees in four countries; FY2025 net sales SEK 16,039 million.
Ambea is a competency-based care company serving elderly people, people with disabilities and people needing psychosocial support in Sweden, Norway, Denmark and Finland, with municipalities and Finnish wellbeing services counties as its clients. It runs around 1,050 units through brands such as Vardaga, Nytida, Stendi, Altiden, Validia and Klara, mostly as Own Management care places in long-leased premises (81% of 2025 sales). FY2025 net sales were SEK 16,039 million (+13%), adjusted EBITA SEK 1,535 million (9.6% margin) and profit SEK 665 million. It has more than 41,000 employees, is headquartered in Solna and has been listed on Nasdaq Stockholm since 2017; it acquired 98% of Humana in October 2026.
Business units
Vardaga (elderly care, Sweden)
34% of 2025 net sales (SEK 5,454 million)Over 100 nursing homes and home care for around 8,000 care receivers, about 60% under Own Management and 40% under Contract Management, concentrated in Stockholm-Mälaren, Skåne and the West Coast. Q3 2026 EBITA rose 25% to SEK 222 million on occupancy, and it holds most of the construction pipeline. Led by Susanne Sjöberg.
Nytida (social care and schools, Sweden)
29% of 2025 net sales (SEK 4,598 million)Disability care, individual and family care and special needs schools for more than 5,000 care receivers in around 470 units. Its Q3 2026 margin was 17.9%, and it acquired Imera AB (LSS group homes) on 1 October 2026. Led by Fredrik von Malmborg.
Stendi (social care, Norway)
21% of 2025 net sales (SEK 3,288 million)Norway's largest care provider, offering disability and psychosocial care, foster and children's homes and personal assistance in more than 300 units. Its 2025 margin fell to 7.2% on lower occupancy, then recovered to 12.9% in Q3 2026 on staffing efficiency. Led by Ingvild Kristiansen.
Altiden (elderly and social care, Denmark)
8% of 2025 net sales (SEK 1,331 million)Denmark's largest private care provider with about 50 units, including nursing homes, social care and a special needs school. Four contract management operations, about SEK 320 million of annualised revenue, return to municipalities in H1 2027, while new Own Management homes are signed under Denmark's 2025 reform. Led by Trine Mottlau.
Validia (social care, Finland)
7% of 2025 net sales (SEK 1,173 million, from 1 April 2025)Acquired 1 April 2025: about 50 units offering disability care, personal assistance, rehabilitation and, since Q4 2025, child and youth care through bolt-ons. It is Ambea's fastest-growing area (+17% in local currency in Q3 2026) and treated as a growth platform. Led by Laura Ämmälä.
Klara (competence and staffing, Sweden)
1% of 2025 net sales (SEK 387 million)Mobile teams of licensed healthcare professionals, student health services for around 170 schools and temporary nurses and social workers. Sales fell 5% in 2025 on weaker demand, then grew 6% in Q3 2026.
Strategic priorities
- Integrating Humana
- Humana, consolidated from 1 October 2026, brings pro forma annual revenue to SEK 25 billion excluding Swedish personal assistance; SEK 120 million of cost synergies are to be realised during 2027.
- Own Management capacity
- 2,444 Own Management care places are under construction (+51%), estimated at about SEK 3 billion of annual revenue once ramped up; 1,088 places were signed in the first nine months of 2026.
- Financial targets
- Growth of 8-10% a year, an adjusted EBITA margin of 9.5% (to be regained during 2028 after the Humana dip), leverage below 3.25x and a 30% dividend payout.
- Quality through competence and technology
- The new Nordic quality management system MiraQ replaces four older systems and enables predictive analysis and AI; the Lära hub trains about 13,000 people a year.
- Recruitment
- Ambea aims to create 3,500 new jobs in the Nordic care sector over five years as its capacity expands.
Latest results
In Q3 2026 net sales rose 8% to SEK 4,447 million (organic 5%) and adjusted EBITA to SEK 668 million (570), a 15.0% margin against 13.9%, driven by occupancy at Vardaga and Nytida and staffing efficiency at Nytida and Stendi. For the first nine months, net sales were SEK 13,054 million (+10%) and adjusted EBITA SEK 1,445 million (+22%), an 11.1% margin. Leverage excluding IFRS 16 rose to 2.7x from 2.3x at year-end after share buybacks for the Humana deal. Management expects the margin to fall below the 9.5% target with Humana and return to it during 2028.
Investments and deals
- Humana acquisition
- 98% of Humana acquired after Q3 2026 for SEK 3,423 million (SEK 932 million cash, SEK 2,491 million in shares); its Swedish Personal Assistance business will be divested within 12 months.
- Validia acquisition
- Validia, acquired 1 April 2025, brought Ambea into Finland with about 50 units; it has since bought child and youth care businesses including Attendo Lastensuojelupalvelut, Sauma and Ehot.
- New care places
- 272 Own Management care places opened in 2025; Vardaga Villa Primus (160 apartments) opens in 2028 and two Stockholm-area nursing homes (220 places) were signed in Q3 2026.
- Bolt-on acquisitions
- AvAsta, Serigmo Care and Villa Arelid in 2025 and Imera AB on 1 October 2026.
Challenges and risks
- Municipal budget pressure
- Clients face social welfare costs growing faster than revenues, and price indexation may lag cost inflation, with personnel the largest expense.
- Occupancy of new units
- Own Management start-ups carry occupancy risk and long leases; Stendi's 2025 margin fell to 7.2% on lower and more fluctuating occupancy.
- Contract losses
- Confirmed net contract management terminations over the next 12 months total SEK -410 million, including Altiden's four operations returning to municipalities.
- Integration and leverage
- Humana is the largest transaction in Ambea's history, with illustrative net debt of about 3.5x EBITDA after completion and a temporary margin dilution.
- Staff shortages and security
- Recruiting and retaining managers, nurses and care workers, cyber threats and criminals seeking jobs in social care are named risks.
What leadership says
“This is the largest transaction in Ambea's history”
“These are future capacity opportunities, not immediate revenue.”
“we only pursue growth when quality can be assured”
“an opportunity to create an even stronger pan-Nordic care provider”
Where a supplier can help
- Post-merger integration support
- Tied to the Humana integration priority: consolidating group functions, offices and systems to reach SEK 120 million of synergies during 2027 creates needs for IT, HR and finance integration.
- Recruitment and training
- Tied to the recruitment priority and staff shortage challenge: 3,500 new jobs and a 2,444-place pipeline call for recruiting, onboarding and learning tools.
- Care data and AI
- Tied to the MiraQ rollout: data platforms, predictive analytics and welfare technology fit the stated push to apply AI to care data across more than 1,000 units.
- Construction and fit-out of care homes
- Tied to Own Management capacity: new nursing homes and residential facilities opening through 2030 need fit-out, equipment and facility services.
- Security and compliance
- Tied to the cyber and infiltration risks: identity checks, cyber security and licence compliance services address named risks.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Ambea?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report with Quality & Sustainability Report 2025
- Ambea is the Nordics' leading competency-based care company: around 1,050 units, more than 41,000 employees, 18,000 care receivers and 490 municipalities/wellbeing services counties as clients across Sweden, Norway, Denmark and Finland; listed on Nasdaq Stockholm since 2017, HQ in Solna.
- FY2025 record year: net sales SEK 16,039 million (+13%; organic 4%, acquired 10%), adjusted EBITA SEK 1,535 million (+12%), adjusted EBITA margin 9.6% (9.7), profit for the year SEK 665 million, EPS SEK 7.95; free cash flow SEK 2,052 million.
- Six business areas: Vardaga (Swedish elderly care, 34% of sales), Nytida (Swedish social care and schools, 29%), Stendi (Norway, 21%), Altiden (Denmark, 8%), Validia (Finland, 7%, acquired 1 April 2025) and Klara (staffing, 1%), plus the Lära training hub.
- Own Management (long leases of 10-15 years, care places sold to municipalities) is 81% of sales, Contract Management 18%, competence and staffing 1%; 272 new Own Management care places opened in 2025.
- Growth through openings and bolt-ons: Validia brought Ambea into Finland (about 50 units, 1,400 care places, 2,600 employees); AvAsta, Attendo Lastensuojelupalvelut, Serigmo Care and Villa Arelid also acquired; Vardaga Villa Primus (160 apartments) due in 2028.
- Financial targets: growth 8-10% (13% in 2025), adjusted EBITA margin 9.5% (9.6%), leverage below 3.25x (2.3x), dividend payout 30% (33%); proposed dividend SEK 2.65 per share.
- Strategy rests on four focus areas: customer-focused care services, quality through competence, time for care, and innovation and welfare technology (Ambea Innovation Hub, generative AI tested by around 100 unit managers, new Nordic quality management system to roll out in 2026).
- Key risks: municipal budget pressure and price indexation, occupancy of new Own Management units, staff shortages, licences, long leases, acquisitions, cyber threats and crime infiltrating social care.
- CEO Mark Jensen sees a structural shortage of care places, backs care-home guarantees in Sweden and praises Denmark's new Elderly Care Act; priorities for 2026 are expanding Validia and Own Management capacity.
- Interim report January-September 2026 (Q3 2026)
- Q3 2026: net sales SEK 4,447 million (+8%; organic 5%, acquired 2%, currency 1%); adjusted EBITA SEK 668 million (570), margin 15.0% (13.9); EBIT SEK 619 million; EPS SEK 4.86 (3.83).
- Nine months: net sales SEK 13,054 million (+10%); adjusted EBITA SEK 1,445 million (+22%), margin 11.1% (10.0); free cash flow SEK 1,449 million.
- Humana offer completed after the quarter: 98% of shares acquired for SEK 3,423 million (SEK 932 million cash, SEK 2,491 million in shares), consolidated from 1 October 2026; Humana's Swedish Personal Assistance to be divested within 12 months.
- Nytida acquired Imera AB (LSS group homes, revenue SEK 77 million) on 1 October.
- Pipeline of Own Management care places under construction reached 2,444, nearly 2,500 per the CEO; Vardaga signed two Stockholm-area nursing homes (220 places).
- Vardaga EBITA +25% to SEK 222 million (margin 15.2%); Nytida margin 17.9%; Stendi margin 12.9%; Altiden margin 14.1%.
- Altiden loses four elderly care contract management operations to remunicipalisation in H1 2027, about SEK 320 million of annualised revenue.
- Net debt excluding IFRS 16 2.7x rolling adjusted EBITDA (2.3x at year-end) after buying back 5,560,658 shares for the Humana deal.
- Interim report January-June 2026 (Q2 2026)
- Q2 2026: net sales SEK 4,387 million (+7%; organic 4%, acquired 2%, currency 1%); adjusted EBITA SEK 397 million (311), margin 9.0% (7.6); EPS SEK 2.13 (1.13).
- H1 2026: net sales SEK 8,607 million (+11%); adjusted EBITA SEK 777 million (618), margin 9.0% (8.0); free cash flow SEK 863 million (688).
- Announced a recommended public offer for all shares in Humana to combine the two companies, with a buyback of up to 5,560,658 own shares; SEK -19 million of transaction costs in the quarter.
- Vardaga EBITA +24% to SEK 143 million in Q2 on occupancy; Nytida EBITA +17% to SEK 148 million; Stendi EBITA SEK 54 million (29) after operational adjustments.
- Validia bought Ehot Oy (child and youth care, revenue SEK 40 million) on 1 June; Altiden signed for a combined nursing home (88 places) and social care facility, enabled by Denmark's 2025 elderly care reform.
- More care places signed in H1 than in any previous full year; Ambea aims to create 3,500 new jobs over five years.
- New Nordic quality management system MiraQ live in Sweden, rolling out elsewhere in H2; it replaces four older systems and enables predictive analysis and AI.
- Klara sales fell 11% in Q2 on weaker demand; Quality Index 7.80 (target above 7.50), eNPS +25.
- Ambea recommended public offer for Humana - webcast and conference call (transcript)
- Conference call of 29 June 2026 announcing Ambea's recommended public offer for Humana, presented by CEO Mark Jensen with CFO Benno Eliasson in Q&A.
- Offer worth SEK 62.30 per Humana share (SEK 20 cash plus 0.305 Ambea shares), about SEK 2.96 billion equity value, a 26.8% premium, plus a contingent value right tied to Humana's legal claim against the Swedish state.
- Combined group: more than 25,000 care receivers and more than 60,000 care professionals; Ambea strong in elderly and residential disability care, Humana in individual and family care for children and young people.
- Humana's Swedish Personal Assistance business to be divested, with a put option to Impilo if no buyer is found within 12 months.
- Cost synergies of about SEK 120 million a year, fully realised in the second year; illustrative net debt about 3.5x EBITDA after completion; accretive to adjusted EPS in the first full year.
- Combined EBITDA margin excluding Swedish Personal Assistance about 8.4% in 2025; target to return to the 9.5% margin on a run-rate basis towards the end of 2028; financial targets reconfirmed.
- Jensen keeps all of Humana's more than 400 units and says Validia's integration is finished, so Ambea has capacity to absorb Humana.
- Ambea Q3 2026 earnings call (transcript)
- Q3 2026 results call of 4 November 2026 with CEO Mark Jensen and CFO Benno Eliasson.
- Rolling 12-month net sales almost SEK 17.3 billion and adjusted EBITA margin 10.4%; Q3 adjusted EBITA SEK 668 million, margin 15.0%.
- Pipeline of Own Management care places under construction 2,444 (+51% year on year); 1,088 new places signed in nine months versus 659 in all of 2025; the full pipeline is estimated at about SEK 3 billion of annual revenue once ramped up.
- Humana is the largest transaction in Ambea's history; pro forma annual revenue reaches SEK 25 billion excluding Swedish personal assistance; SEK 120 million synergies to be realised during 2027.
- Margin will dip below the 9.5% target with Humana and return to it during 2028; growth target of 8-10% a year from 2028 kept.
- Rolling 12-month free cash flow excluding IFRS 16 exceeded SEK 1 billion for the first time; leverage 2.7x excluding IFRS 16.
- Vardaga is near full occupancy; Nytida still has room; Stendi heading back to market-level margins of 8-9%; Denmark will have no contract management business from Q3 2027.
Questions about Ambea
What does Ambea do?
Ambea provides elderly care, disability care, individual and family care, special needs schools and care staffing in Sweden, Norway, Denmark and Finland, mostly for municipalities and wellbeing services counties.
What is Ambea's revenue?
FY2025 net sales were SEK 16,039 million (+13%). With Humana, pro forma annual revenue reaches SEK 25 billion excluding Swedish personal assistance.
How many employees does Ambea have?
More than 41,000 employees at end-2025; combined with Humana, more than 60,000 care professionals.
Who leads Ambea?
Mark Jensen has been President and CEO since 2021, Benno Eliasson is CFO and Yrjö Närhinen chairs the board.
What is Ambea's strategy?
Ambea grows through new Own Management care places and acquisitions such as Validia and Humana, targeting 8-10% annual growth and a 9.5% adjusted EBITA margin, with a focus on quality through competence and welfare technology.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)